SynthesisScientific reports2022

Efficacy and safety of dulaglutide compared with the first-line hypoglycemic drugs in Asian patients with type 2 diabetes: a systematic review and meta-analysis.

Bin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.